Speaking of DTC, here's what I had to share with Mike Schneider on Bloomberg TV:
vimeo.com/1020779
Speaking to an FDA advisory committee is one thing, speaking to the American public --the ultimate advisory committee -- is something else entirely.
(And the latter is more intimidating.)
vimeo.com/1020779
Speaking to an FDA advisory committee is one thing, speaking to the American public --the ultimate advisory committee -- is something else entirely.
(And the latter is more intimidating.)